John J. Harrington, Chief Scientific Officer at ATHERSYS, INC / NEW (ATHX), sold 23,769 shares at $1.65 ($39K) on 2014-06-18, disclosed to the SEC on 2014-06-19.
Scheduled sale ($39k) by Chief Scientific Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.65 | 4,075 | $7K | 17.2% |
| 2 | $1.65 | 15,619 | $26K | 65.9% |
| 3 | $1.62 | 4,075 | $7K | 16.9% |
| Total | $1.64 avg | 23,769 | $39K | 100% |
| Filing → |
| ATHX | SELL | 2021-06-08 | $47K | — | Filing → |
| ATHX | SELL | 2021-06-02 | $36K | — | Filing → |
| ATHX | SELL | 2021-03-17 | $20K | — | Filing → |